Trade VVOS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Vivos Therapeutics, Inc. (VVOS) is trading at US$0.19, up 6.76% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$5.98M. Over the past 52 weeks, VVOS has traded between US$0.16 and US$4.13. On Syfe you can trade VVOS with $0 commission and add it to your watchlist.
| Previous close | US$0.17 |
|---|---|
| Market cap | US$5.98M |
| 52-week range | US$0.16 – US$4.13 |
| Volume | 4.35M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.
Year: 2020
Top Premarket Decliners
Aug 5, 11:37 AM · MT Newswires
Sector Update: Healthcare Stocks Rise Late Afternoon
Jun 22, 7:43 PM · MT Newswires
Vivos Therapeutics Extends Financing Agreement With Streeterville Through August
Jun 22, 1:23 PM · MT Newswires
Vivos Therapeutics, Inc. (VVOS) stock is trading at US$0.19, +6.76% from the previous close of US$0.17.
The market cap for Vivos Therapeutics, Inc. (VVOS) stock is approximately US$5.98M.
The 52-week high for Vivos Therapeutics, Inc. (VVOS) stock is US$4.13.
The 52-week low for Vivos Therapeutics, Inc. (VVOS) stock is US$0.16.
Vivos Therapeutics, Inc. (VVOS) does not currently pay a dividend.
Stay on top of VVOS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
